Clinical characteristics and outcomes of Chinese patients with KRAS-mutant non-small cell lung cancer after chemotherapy

被引：2
|
作者：
Zheng, Yawen [1 ,2 ]
Lai, Qinghua [1 ]
Zhao, Hanxi [2 ]
Li, Xiaolin [2 ]
Sun, Xiaorong [2 ]
Xing, Ligang [2 ]
机构：
[1] Shandong First Med Univ, Cent Hosp, Shandong Univ, Dept Oncol,Jinan Cent Hosp,Cheeloo Coll Med, Jinan 250013, Shandong, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Shandong Key Lab Radiat Oncol, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China
来源：
CANCER COMMUNICATIONS | 2021年 / 41卷 / 11期
关键词：
D O I：
10.1002/cac2.12227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1234 / 1238
页数：5
相关论文
共 50 条
  • [1] KRAS-B: Molecular Epidemiology and Clinical Outcomes of KRAS-Mutant Non-small Cell Lung Cancer (NSCLC) in Brazil
    De Marchi, P.
    Aguiar, P., Jr.
    Paes, R. Duarte
    Montella, T.
    Afonso, N. Gimenes
    Negreiros, I. Santos
    Vasconcelos Visani, F. L.
    Barcellos, I. Favato
    Viana Veloso, G. G.
    Reis, M. Xavier
    Mathias, C.
    Zalis, M.
    Dienstmann, R.
    Ferreira, C. Gil
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S453 - S453
  • [2] Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer
    Aredo, J.
    Padda, S.
    Kunder, C.
    Han, S.
    Wakelee, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1133 - S1133
  • [3] KRAS-Mutant non-small cell lung cancer: From biology to therapy
    Ferrer, Irene
    Zugazagoitia, Jon
    Herbertz, Stephan
    John, William
    Paz-Ares, Luis
    Schmid-Bindert, Gerald
    [J]. LUNG CANCER, 2018, 124 : 53 - 64
  • [4] Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
    Zhang, Jun
    Park, Dongkyoo
    Shin, Dong M.
    Deng, Xingming
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (01) : 11 - 16
  • [5] The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer
    Chen, Hanxiao
    Huang, Dingzhi
    Lin, Gen
    Yang, Xue
    Zhuo, Minglei
    Chi, Yujia
    Zhai, Xiaoyu
    Jia, Bo
    Wang, Jingjing
    Wang, Yuyan
    Li, Jianjie
    An, Tongtong
    Wu, Meina
    Wang, Ziping
    Zhao, Jun
    [J]. CANCER MEDICINE, 2022, 11 (19): : 3581 - 3592
  • [6] Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
    Arbour, Kathryn C.
    Jordan, Emmett
    Kim, Hyunjae Ryan
    Dienstag, Jordan
    Yu, Helena A.
    Sanchez-Vega, Francisco
    Lito, Piro
    Berger, Michael
    Solit, David B.
    Hellmann, Matthew
    Kris, Mark G.
    Rudin, Charles M.
    Ni, Ai
    Arcila, Maria
    Ladanyi, Marc
    Riely, Gregory J.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (02) : 334 - 340
  • [7] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
    Jacqueline V. Aredo
    Sukhmani K. Padda
    [J]. Current Treatment Options in Oncology, 2018, 19
  • [8] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Giorgia Maroni
    Mahmoud A. Bassal
    Indira Krishnan
    Chee Wai Fhu
    Virginia Savova
    Rapolas Zilionis
    Valerie A. Maymi
    Nicole Pandell
    Eva Csizmadia
    Junyan Zhang
    Barbara Storti
    Julio Castaño
    Riccardo Panella
    Jia Li
    Corinne E. Gustafson
    Sam Fox
    Rachel D. Levy
    Claire V. Meyerovitz
    Peter J. Tramontozzi
    Kimberly Vermilya
    Assunta De Rienzo
    Stefania Crucitta
    Daniela S. Bassères
    Marla Weetall
    Art Branstrom
    Alessandra Giorgetti
    Raffaele Ciampi
    Marzia Del Re
    Romano Danesi
    Ranieri Bizzarri
    Henry Yang
    Olivier Kocher
    Allon M. Klein
    Robert S. Welner
    Raphael Bueno
    Maria Cristina Magli
    John G. Clohessy
    Azhar Ali
    Daniel G. Tenen
    Elena Levantini
    [J]. Communications Biology, 4
  • [9] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
    Aredo, Jacqueline V.
    Padda, Sukhmani K.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)
  • [10] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Maroni, Giorgia
    Bassal, Mahmoud A.
    Krishnan, Indira
    Fhu, Chee Wai
    Savova, Virginia
    Zilionis, Rapolas
    Maymi, Valerie A.
    Pandell, Nicole
    Csizmadia, Eva
    Zhang, Junyan
    Storti, Barbara
    Castano, Julio
    Panella, Riccardo
    Li, Jia
    Gustafson, Corinne E.
    Fox, Sam
    Levy, Rachel D.
    Meyerovitz, Claire, V
    Tramontozzi, Peter J.
    Vermilya, Kimberly
    De Rienzo, Assunta
    Crucitta, Stefania
    Basseres, Daniela S.
    Weetall, Marla
    Branstrom, Art
    Giorgetti, Alessandra
    Ciampi, Raffaele
    Del Re, Marzia
    Danesi, Romano
    Bizzarri, Ranieri
    Yang, Henry
    Kocher, Olivier
    Klein, Allon M.
    Welner, Robert S.
    Bueno, Raphael
    Magli, Maria Cristina
    Clohessy, John G.
    Ali, Azhar
    Tenen, Daniel G.
    Levantini, Elena
    [J]. COMMUNICATIONS BIOLOGY, 2021, 4 (01)
12345